BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35005971)

  • 1. Enhancing the Kinetic Stability of Polymeric Nanomicelles (PLGA) Using Nano-Montmorillonite for Effective Targeting of Cancer Tumors.
    Karataş D; Bahadori F; Tekin A; Ergin Kizilcay G; Celik MS
    J Phys Chem B; 2022 Jan; 126(2):463-479. PubMed ID: 35005971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B; Ranganathan B; Feng SS
    Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of composite poly(d,l-lactide)/montmorillonite nanoparticles for controlled delivery of acetaminophen by solvent-displacement method using glass capillary microfluidics.
    Othman R; Vladisavljević GT; Thomas NL; Nagy ZK
    Colloids Surf B Biointerfaces; 2016 May; 141():187-195. PubMed ID: 26852102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.
    Li Z; Liu K; Sun P; Mei L; Hao T; Tian Y; Tang Z; Li L; Chen D
    J Microencapsul; 2013; 30(5):432-40. PubMed ID: 23517067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of PLGA-DSPE hybrid nano-micelles with enhanced hydrophobic capacity for curcumin delivery.
    Balıbey FB; Bahadori F; Ergin Kizilcay G; Tekin A; Kanimdan E; Kocyigit A
    Pharm Dev Technol; 2023 Nov; 28(9):843-855. PubMed ID: 37773031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and assessment of CTAB and NPE modified organo-montmorillonite for the fabrication of organo-montmorillonite/alginate based hydrophobic pharmaceutical controlled-release formulation.
    Yan H; Chen X; Bao C; Yi J; Lei M; Ke C; Zhang W; Lin Q
    Colloids Surf B Biointerfaces; 2020 Jul; 191():110983. PubMed ID: 32208326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin-loaded electrospun polycaprolactone/montmorillonite nanocomposite: wound dressing application with anti-bacterial and low cell toxicity properties.
    Sadeghianmaryan A; Yazdanpanah Z; Soltani YA; Sardroud HA; Nasirtabrizi MH; Chen X
    J Biomater Sci Polym Ed; 2020 Feb; 31(2):169-187. PubMed ID: 31609684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies.
    Alhowyan AA; Altamimi MA; Kalam MA; Khan AA; Badran M; Binkhathlan Z; Alkholief M; Alshamsan A
    J Microbiol Methods; 2019 Jun; 161():87-95. PubMed ID: 30738109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer Treatment.
    Saha C; Kaushik A; Das A; Pal S; Majumder D
    PLoS One; 2016; 11(5):e0155710. PubMed ID: 27196562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green Synthesized Montmorillonite/Carrageenan/Fe
    Yew YP; Shameli K; Mohamad SE; Lee KX; Teow SY
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32659939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
    Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
    AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
    Akhter MH; Kumar S; Nomani S
    Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
    He X; Ma J; Mercado AE; Xu W; Jabbari E
    Pharm Res; 2008 Jul; 25(7):1552-62. PubMed ID: 18196205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
    Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
    Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
    J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.